Clinicalusedefinition-contraindication-example

R6 Ballot (2nd Draft)

This page is part of the FHIR Specification v6.0.0-ballot2: Release 6 Ballot (2nd Draft) (see Ballot Notes). The current version is 5.0.0. For a full list of available versions, see the Directory of published versions

Example ClinicalUseDefinition/example-contraindication (Narrative)

Biomedical Research and Regulation Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ClinicalUseDefinition.

Generated Narrative: ClinicalUseDefinition example-contraindication

type: contraindication

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/example/MPID#{mpid}; classification = B01AF02

contraindication
DiseaseSymptomProcedures

- Concept

* Concomitant treatment with any other anticoagulant agent
otherTherapy
relationshipType: Co-therapy(with)
Treatments

- Concept

* Oralanticoagulants
otherTherapy
relationshipType: Co-therapy(with)
Treatments

- Concept

* Lowmolecularweightheparins

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.